Listed by the USPTO as HUANG, GIGI GEORGIANA
Tech Center 1600 • Art Units: 1611 1612 1613 1617 1621 1627 1629
This examiner grants 32% of resolved cases
HUANG, GIGI GEORGIANA is assigned to Tech Center 1600 and Art Unit 1611. The profile records 610 resolved cases, an allowance rate of 31.8%, and a median of 1433 days to allowance. The interview lift is 30.8%, making examiner interviews a particularly important consideration when developing a response plan for difficult prosecution matters.
3M Innovative Properties Company, Colgate-Palmolive Company, and Trustees of Tufts College are the listed companies. WILSON SONSINI GOODRICH & ROSATI, THORPE NORTH & WESTERN, LLP., and AMPACC Law Group, PLLC are the listed firms. Counsel may benefit from emphasizing clear claim positions, preparing for extended prosecution, and using interviews to test amendments before filing.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18576822 | FILM-FORMING COMPOSITIONS COMPRISING SALICYLIC ACID AND METHODS OF USE | Non-Final OA | 3M INNOVATIVE PROPERTIES COMPANY |
| 18546258 | TREATMENT OF MYOPIA | Non-Final OA | University of Utah Research Foundation |
| 18400940 | PEROXYMONOSULFATE ORAL WHITENING COMPOSITIONS | Non-Final OA | Colgate-Palmolive Company |
| 18518772 | COMPOSITION FOR IMPROVING OR PREVENTING IRON DEFICIENCY ANAEMIA | Non-Final OA | AJINOMOTO CO., INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy31.8% of resolved applications examined by Gigi Georgiana Huang were allowed (610 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +30.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Gigi Georgiana Huang took 1,433 days on average from filing to allowance.
Gigi Georgiana Huang examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
